Peter Blume-jensen
biotechnology
Veritas Genetics
China
Biography
Scientific leader in personalized oncology, targeted oncology therapeutics, and biomarker research. Currently CSO Xtuit. Former executive with Metamark Genetics, Daiichi Sankyo, Merck and Serono.
Research Interest
biomarkers